Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study

Diabetes Research and Clinical Practice

Volumn 78, Issue 2, 2007, Pages 254-258

  Houlden, Robyn ^a   Ross, Stuart ^b   Harris, Stewart ^c   Yale, Jean Francois ^d   Sauriol, Luc ^e   Gerstein, Hertzel C ^f  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Thames Valley Family Practice ^*  (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e SANOFI   (France)

^f HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Diabetes; Insulin glargine; Oral antidiabetic drugs; Quality of life; Randomized controlled trial; Treatment satisfaction

Indexed keywords

HEMOGLOBIN A1C; INSULIN GLARGINE; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA;

ADD ON THERAPY; ADULT; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG CHOICE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE;

EID: 34548845556     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.03.021     Document Type: Article

References (12)

1. Garratt A.M., Schmidt L., and Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review. Diab. Med. 19 (2002) 1-11
2. American Diabetes and Association. Standards of medical care in diabetes. Diab. Care 27 Suppl.1 (2004) S15-S35
3. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can. J. Diab. 27. Suppl. 2 (2003)
4. Leahy J.L. Intensive insulin therapy in Type 1 diabetes mellitus. In: Leahy J.L., and Cefalu W.T. (Eds). Insulin Therapy (2002), Marcel Dekker, New York 87-112
5. Campbell R.K., White J.R., Levien T., and Baker D. Insulin glargine. Clin. Ther. 23 (2001) 1938-1957
6. Riddle M.C., Rosenstock J., and Gerich J. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of Type 2 diabetic patients. Diab. Care 26 (2003) 3080-3086
7. Rosenstock J., Dailey G., Massi-Benedetti M., Fritsche A., Lin Z., and Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in Type 2 diabetes. Diab. Care 28 (2005) 950-955
8. Gerstein H.C., Yale J.F., Harris S.B., Issa M., Stewart J., and Dempsey E. A randomized trial of early glargine use compared to oral agents in insulin naïve people with Type 2 diabetes. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) study. Diab. Med. 23 (2006) 736-742
9. Bradley C. The Diabetes Treatment Satisfaction Questionnaire: DTSQ. In: Bradley C. (Ed). Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice (1994), Harwood Academic Publishers, Chur, Switzerland 111-132
10. Bradley C., Todd C., Gorton T., Symonds E., Martin A., and Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual. Life Res. 8 (1999) 79-91
11. Witthaus E., Stewart J., and Bradley C. Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes. Diab. Med. 18 (2001) 619-625
12. Taylor R., Davies R., Fox C., Sampson M., Weaver J., and Wood L. Appropriate insulin regimens for Type 2 diabetes: a multicenter randomized crossover study. Diab. Care 23 (2000) 1612-1618